News
News

News

03/15/2021 STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology

STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology

Vitiligo Repigmentation Achieved in Five Treatments with XTRAC® Excimer Laser HORSHAM, Pa. , March 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and
03/10/2021 STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

HORSHAM, Pa. , March 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it
03/09/2021 STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.

STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.

New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market HORSHAM, Pa. , March 09, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery
03/01/2021 STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HORSHAM, Pa. , March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences , Inc. (NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,
03/01/2021 STRATA Skin Sciences Announces CEO Transition

STRATA Skin Sciences Announces CEO Transition

HORSHAM, Pa. , March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Robert (Bob) Moccia has been appointed
01/12/2021 STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics

STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics

Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million  Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarter HORSHAM, Pa. , Jan.
01/12/2021 STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”

STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”

HORSHAM, Pa. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the